Corbus Pharmaceuticals
MA - Norwood
Pharmaceutical1 H-1B visas (FY2023)Focus: Orphan inflammatory-fibrotic diseases
Corbus Pharmaceuticals is a life sciences company focused on Orphan inflammatory-fibrotic diseases.
ImmunologyNeurologyRare Diseases
Open Jobs
2
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT07310901A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
Phase 1CRB-701
Solid Tumor, AdultClinical Trials (1)
NCT06265727A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Phase 1/2CRB-601 monoclonal antibody
Solid TumorClinical Trials (1)
NCT06603844First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Phase 1/2Phase 2
Clinical Trials (1)
NCT02465437Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
Phase 2JBT-101
DermatomyositisClinical Trials (1)
NCT02466243Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Phase 2Lenabasum 20 mg
Cystic FibrosisClinical Trials (1)
NCT03451045Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Phase 2JBT-101
Systemic Lupus ErythematosusClinical Trials (1)
NCT03093402JBT-101 in Systemic Lupus Erythematosus (SLE)
Phase 2JBT-101
Cystic FibrosisClinical Trials (1)
NCT02465450Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
Phase 2Lenabasum 20 mg
DermatomyositisClinical Trials (1)
NCT03813160Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Phase 3Lenabasum 5 mg
Diffuse Cutaneous Systemic SclerosisClinical Trials (1)
NCT03398837Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Phase 3Open Jobs (2)
Interview Prep Quick Facts
Portfolio: 10 clinical trials
H-1B (2023): 1 approval
Open Roles: 2 active jobs
Hiring Trend
Stable
2
Open Roles
+0
Added
-1
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub